PMID- 8920998 OWN - NLM STAT- MEDLINE DCOM- 19961230 LR - 20190501 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 319 ( Pt 3) IP - Pt 3 DP - 1996 Nov 1 TI - The lysosomal Ca2+ pool in MDCK cells can be released by ins(1,4,5)P3-dependent hormones or thapsigargin but does not activate store-operated Ca2+ entry. PG - 909-12 AB - In several cell types, Ca2+ release from intracellular Ca2+ stores by Ins(1,4,5)P3 elicits Ca2+ influx from the extracellular space into the cytoplasm, termed store-operated Ca2+ entry (SOCE). In MDCK cells, the Ins(1,4,5)P3-sensitive Ca2+ store giving rise to SOCE essentially overlaps with the thapsigargin (TG)-sensitive store. Recent evidence suggests that in MDCK cells lysosomes form a Ca2+ pool that is functionally coupled with the Ins(1,4,5)P3-sensitive Ca2+ store: Ca2+ can be selectively released from lysosomes by glycyl-L-phenylalanine naphthylamide, an agent inducing lysosomal swelling with subsequent and reversible permeabilization of the vesicular membranes. This compartment is also depleted by Ins(1,4,5)P3-dependent agonists or TG, indicating that it is part of a larger, Ins(1,4,5)P3-sensitive Ca2+ pool. Here we show that whereas SOCE is triggered by Ca2+ release from the entire Ins(1,4,5)P3-sensitive Ca2+ pool, selective Ca2+ release from lysosomes alone is unable to trigger SOCE. This finding is consistent with measurements of the store-operated cation current, a direct parameter for store-operated Ca2+ and Na+ entry into MDCK cells. Hence it is proposed that the Ins(1,4,5)P3-sensitive Ca2+ pool is composed of different intracellular compartments that do not uniformly stimulate Ca2+ entry into the cell. FAU - Haller, T AU - Haller T AD - Department of Physiology, University of Innsbruck, Austria. FAU - Volkl, H AU - Volkl H FAU - Deetjen, P AU - Deetjen P FAU - Dietl, P AU - Dietl P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Dipeptides) RN - 21438-66-4 (glycylphenylalanine 2-naphthylamide) RN - 67526-95-8 (Thapsigargin) RN - 85166-31-0 (Inositol 1,4,5-Trisphosphate) RN - 9NEZ333N27 (Sodium) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/*metabolism MH - Cell Line MH - Dipeptides/pharmacology MH - Dogs MH - Inositol 1,4,5-Trisphosphate/*metabolism MH - Intracellular Membranes/drug effects/physiology MH - Kidney MH - Kinetics MH - Lysosomes/drug effects/*physiology MH - Membrane Potentials MH - Sodium/metabolism MH - Thapsigargin/*pharmacology PMC - PMC1217874 EDAT- 1996/11/01 00:00 MHDA- 1996/11/01 00:01 PMCR- 1997/05/01 CRDT- 1996/11/01 00:00 PHST- 1996/11/01 00:00 [pubmed] PHST- 1996/11/01 00:01 [medline] PHST- 1996/11/01 00:00 [entrez] PHST- 1997/05/01 00:00 [pmc-release] AID - 10.1042/bj3190909 [doi] PST - ppublish SO - Biochem J. 1996 Nov 1;319 ( Pt 3)(Pt 3):909-12. doi: 10.1042/bj3190909.